rhoeae in 21 and 12.3% of the cases, respectively (1, 2) . For all these reasons, routine therapy for uncomplicated gonorrhea in heterosexual men and women may require new treatment modalities that should be effective against all these pathogens (21). Also, these compounds could be useful in the treatment of infectious diseases of the female genital tract, such as salpingitis, where all of these pathogens are often implicated in mixed infections with anaerobic bacteria.
In this paper we report on the in vitro activity of four quinoline carboxylic acid derivatives against recently isolated strains, one each of N. gonorrhoeae, C. trachomatis, and U. urealyticum.
MATERIALS AND METHODS
Strains. A total of 48 ,B-lactamase-negative strains of N. gonorrhoeae, 10 of C. trachomatis, and 32 of U. urealyticum were used. All the strains were isolated from patients with genital diseases who were attending the Sexually Transmitted Diseases Clinic of the School of Medicine, University of Seville.
Antimicrobial agents. The antimicrobial agents used were ciprofloxacin (Bayer Pharmaceuticals), norfloxacin (Merck Sharp & Dohme) ofloxacin (Hoeschst Iberica), enoxacin (Warner Lambert Co.), and doxycycline (Pfizer Inc.) .
N. gonorrhoeae tests. Susceptibility tests were performed by an agar dilution method with D.S.T. agar base (Oxoid Ltd.) supplemented with 5% horse blood and 1% Saponin (12) . Twofold serial concentrations from 0.0015 to 3.2 ,ug of the antibacterial agents per ml were incorporated into the medium. The inoculum was adjusted to deliver 104 CFU per spot. All plates were incubated for 24 h at 37°C in candle jars. The MIC was read as the lowest concentration of antibacterial drug that completely inhibited growth. In each experiment, World Health Organization N. gonorrhoeae reference strains III, IV, and VII (A. Reyn, Statens Serum Institut, Copenhagen, Denmark) were included. The median MICs of penicillin against these strains were 0.1 pug/ml, Reyn III; 0.2 ,ug/ml, Reyn V; and 0.01 ,ug/ml, Reyn VII.
C. trachomatis tests. Susceptibility tests were done as previously described (17) . Briefly, standard inocula of chlamydial isolates treated to yield ca. 100 to 1,000 inclusion-forming units per cover slip were used to infect cycloheximide-treated McCoy cells. At 60 min after centrifugation (2,000 x g at 35°C) of inoculum onto the cells, the medium was replaced with 1 ml of tissue culture medium (Eagle minimal essential medium supplemented with 5% fetal bovine serum, 1% glutamine, and 1% vitamins) containing the antimicrobial agents to be tested. Doubling concentrations of 0.03 to 64 ,ug/ml were used.
Tubes were incubated for 48 h at 36°C, after which the cover slips were removed, stained with Giemsa stain, and examined for the presence of inclusions by use of dark-field microscopy at a magnification of x 100.
The MIC was defined as the lowest concentration of antimicrobial agent that prevented the appearance of any inclusion bodies in the cell monolayer. The minimal lethal concentration (MLC) was defined as the lowest concentration of drug that completely inhibited further multiplication of C. trachomatis after removal of the drug. The MLC was determined after a two-passage technique (18) , and no further C. trachomatis inclusions appeared.
In each experiment two laboratory strains, serotypes Li (440L), and L2 (434B), kindly supplied by the Institute of Ophthalmology of London, were included. The results obtained with doxycycline were an MIC of 0.03 ,g/ml and an MLC of 0.12 ,ug/ml against strain 440L and an MIC of 0.03 ,ug/ml and an MLC of 0.06 ,ug/ml against strain 434 B.
U. urealyticum tests. Susceptibility tests were performed by a broth dilution method (20) with Boston broth S2 (11) . Twofold serial concentrations of the antimicrobial drugs were incorporated into the medium. The inoculum was adjusted to 104 to 105 color-changing units per 0.05 ml.
The MIC was defined as the lowest concentration of antimicrobial agent that inhibited color change at 48 h of incubation. The MBC was determined by subculturing in Boston broth free of antimicrobial agent and was defined as the lowest concentration of drug that prevented color change at 48 h of incubation. RESULTS AND DISCUSSION Table 1 shows the MICs of the four quinoline carboxylic acids for 50 and 90% of the 48 N. gonorrhoeae strains (MIC50 and MIC90), All these compounds showed excellent activity against N. gonorrhoeae; ciprofloxacin was the most active, with an MIC90 of s0.0015 ,ug/ml, followed in decreasing order of activity by ofloxacin, norfloxacin, and enoxacin. Our results with ciprofloxacin were similar to those ofWise et al. (23) . Norfloxacin, enoxacin, and ofloxacin seemed to be slightly less active than previously reported (4, 10, 16, 23) . These differences can probably be attributed to differences in the inoculum size and the culture media used.
The antichlamydial activities of these compounds are presented in Table 2 . There were no significant differences between the MLCs and MICs. Among the quinoline derivatives, ciprofloxacin was the most active antichlamydial agent, with an MLCgo of 1 jLg/ml, followed by ofloxacin, with an MIC90 of 4 ,ug/ml, and by enoxacin and norfloxacin.
The results obtained with ciprofloxacin and norfloxacin are in agreement with those previously reported (7, 8) . No data regarding enoxacin or oflaxacin activity against C. trachomatis are available, and our results show that ofloxacin seems to be more active than norfloxacin or enoxacin, although it is less active than ciprofloxacin.
Nevertheless, doxycycline maintained the best activity of all the compounds studied.
The quinoline carboxylic acids showed poor activity against U. urealyticum (Table 3 ). There are no data available for ciprofloxacin, norfloxacin, or enoxacin activity against U. urealyticum. Ofloxacin is the only compound that showed good inhibitory and mycoplasmicidal activity, with an MCB50 and MBC90 of 4 and 8 jig/ml, respectively. Osada and Ogawa reported ofloxacin activity against Mycoplasma hominis and other Mycoplasma species but did not test U. urealyticum (15) . Again, doxycycline showed better activity than the quinoline carboxylic acid derivatives.
We can conclude from these results that of the four quinoline carboxylic acids, ciprofloxacin was the most active against N. gonorrhoeae and C. trachomatis but showed poor bactericidal activity against U. urealyticum, whereas ofloxacin showed the greatest bactericidal activity against 
